Crossover hedge funds that invest in fast-growing public and private companies may have lost tens of billions of clients’ money last year, but that hasn’t deterred some managers from planning to bring more of them to market in the coming

Oil trader Pierre Andurand’s main Andurand Commodities Discretionary Enhanced hedge fund was down 19% last week as oil prices fell below $74 a barrel in New York on the back of global recession fears, according to a report by Bloomberg.

DE Shaw’s flagship hedge fund, the DE Shaw Composite Fund, weathered last year’s high-volatility environment to chalk up gains of 24.7% after fees, ahead of average annual hedge fund industry returns, according to a report by Reuters. The report cites

Catalio Capital Management, a multi-strategy life sciences investment firm with more than $1 billion in assets under management, has launched a dedicated public equities hedge fund investment strategy focused on identifying compelling life science investment opportunities globally. 

Investment manager Neal Berger’s Contrarian Macro Fund chalked up gains of 163% last year on the back of a series of successful bets that US Federal Reserve rate hikes would cause market turmoil, according to a report by Bloomberg. The

New hedge fund launches in the third quarter of 2022 fell lower than the prior quarter, reaching their lowest level since Q4 2008, according to new data released by HFR.

Hedge funds are increasing their bets against the US dollar as speculation grows that the US Federal Reserve is set to slow the pace of recent interest rate hikes aimed at curbing inflation, according to a report by Bloomberg. The

The Rokos Macro Fund has joined a growing group of macro funds to have registered big gains 2022, recovering from its worst ever performance (-26%) in 2021 to record a record gain of 51% last year, according to a report